HUT41984A - Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides - Google Patents

Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides

Info

Publication number
HUT41984A
HUT41984A HU86361A HU36186A HUT41984A HU T41984 A HUT41984 A HU T41984A HU 86361 A HU86361 A HU 86361A HU 36186 A HU36186 A HU 36186A HU T41984 A HUT41984 A HU T41984A
Authority
HU
Hungary
Prior art keywords
alkaloides
ergot
dihydro
pharmaceutical compositions
compositions containing
Prior art date
Application number
HU86361A
Other languages
Hungarian (hu)
Other versions
HU195729B (en
Inventor
Othmar Zueger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858502889A external-priority patent/GB8502889D0/en
Priority claimed from GB858517604A external-priority patent/GB8517604D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of HUT41984A publication Critical patent/HUT41984A/en
Publication of HU195729B publication Critical patent/HU195729B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
HU86361A 1985-02-05 1986-01-24 Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides HU195729B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858502889A GB8502889D0 (en) 1985-02-05 1985-02-05 Co-dergocrine compositions
GB858517604A GB8517604D0 (en) 1985-07-12 1985-07-12 Dihydroergotamine compositions

Publications (2)

Publication Number Publication Date
HUT41984A true HUT41984A (en) 1987-06-29
HU195729B HU195729B (en) 1988-07-28

Family

ID=26288767

Family Applications (1)

Application Number Title Priority Date Filing Date
HU86361A HU195729B (en) 1985-02-05 1986-01-24 Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides

Country Status (24)

Country Link
JP (1) JPS61183225A (en)
KR (1) KR920010388B1 (en)
AU (1) AU597570B2 (en)
BE (1) BE904152A (en)
CA (1) CA1263087A (en)
CH (1) CH667592A5 (en)
CY (1) CY1604A (en)
DE (1) DE3602577A1 (en)
DK (1) DK167138B1 (en)
ES (1) ES8800040A1 (en)
FR (1) FR2576787B1 (en)
GB (1) GB2170407B (en)
GR (1) GR860310B (en)
HK (1) HK57191A (en)
HU (1) HU195729B (en)
IE (1) IE59293B1 (en)
IT (1) IT1191255B (en)
LU (1) LU86289A1 (en)
NL (1) NL8600161A (en)
NZ (1) NZ215020A (en)
PH (1) PH23384A (en)
PT (1) PT81954B (en)
SE (1) SE8600496L (en)
SG (1) SG56191G (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610827B1 (en) * 1987-02-18 1991-09-13 Pf Medicament DIHYDROERGOTAMINE (D.H.E.) TABLET OF THE HYDROPHILIC MATRIX TYPE AND MANUFACTURING METHOD THEREOF
SI8710406B (en) * 1987-03-11 1998-08-31 Lek Sustained release tablets on the basis of high molecular weight hydroxypropylmethylcellulose and a process for their manufacture
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
MXPA02005291A (en) * 1999-12-03 2004-06-21 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof.
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
NZ504526A (en) * 2000-05-12 2003-05-30 Meracol Corp Ltd Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
US6696491B2 (en) 2000-05-12 2004-02-24 Meracol Corporation Limited Treating irritable bowel syndrome or disease
ATE381327T1 (en) * 2000-05-12 2008-01-15 Meracol Corp Ltd CETHYL MYRISTATE AND CETYL PALMITATE FOR THE TREATMENT OF ECZEMA AND/OR PSORIASIS
WO2003026640A1 (en) * 2001-09-28 2003-04-03 Meracol Corporation Limited Treating food allergies and/or food intolerances
CN111297815B (en) * 2020-04-29 2022-04-15 宝利化(南京)制药有限公司 Dihydroergotoxine mesylate sustained-release tablet and preparation method thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
DE3124983A1 (en) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch ORAL ADMINISTRATIVE FORMS
CH649300A5 (en) * 1981-08-07 1985-05-15 Sandoz Ag ERGOPEPTIN DERIVATIVES, THEIR PRODUCTION AND USE.
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3303616A1 (en) * 1982-02-12 1983-08-25 Sandoz-Patent-GmbH, 7850 Lörrach MOTHER CORNAL CALOIDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
JPS604120A (en) * 1983-06-22 1985-01-10 Shionogi & Co Ltd Pharmaceutical preparation of pinacidil of long acting type
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
GB8413795D0 (en) * 1984-05-30 1984-07-04 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
BE904152A (en) 1986-08-04
GR860310B (en) 1986-05-27
PT81954A (en) 1986-03-01
DK167138B1 (en) 1993-09-06
NL8600161A (en) 1986-09-01
GB2170407A (en) 1986-08-06
DE3602577A1 (en) 1986-08-28
CH667592A5 (en) 1988-10-31
DK52086D0 (en) 1986-02-03
FR2576787A1 (en) 1986-08-08
SE8600496D0 (en) 1986-02-04
IT1191255B (en) 1988-02-24
SE8600496L (en) 1986-08-06
GB8602602D0 (en) 1986-03-12
FR2576787B1 (en) 1990-01-12
AU597570B2 (en) 1990-06-07
ES8800040A1 (en) 1987-10-16
IE860291L (en) 1986-08-05
IE59293B1 (en) 1994-02-09
ES551635A0 (en) 1987-10-16
HK57191A (en) 1991-08-02
NZ215020A (en) 1989-07-27
GB2170407B (en) 1988-10-26
KR920010388B1 (en) 1992-11-27
JPS61183225A (en) 1986-08-15
CY1604A (en) 1992-04-03
IT8647620A0 (en) 1986-02-05
SG56191G (en) 1991-08-23
CA1263087A (en) 1989-11-21
AU5294286A (en) 1986-08-14
LU86289A1 (en) 1986-09-02
HU195729B (en) 1988-07-28
PT81954B (en) 1988-07-01
DK52086A (en) 1986-08-06
PH23384A (en) 1989-07-26
KR860006265A (en) 1986-09-09

Similar Documents

Publication Publication Date Title
HUT42321A (en) Process for preparing pharmaceutical compositions
HUT49290A (en) Process for producing retarde pharmaceutical compositions
HUT40453A (en) Process for producing 11-beta-phenyl-gonanes and pharmaceutical compositions containing them
HUT41772A (en) Process for producing /4-substituted-piperazinyl- and -homopiperazinyl/-pyridazines and pharmaceutical compositions containing them
HUT44499A (en) Process for producing 2-thio-methyl-substituted-1,4-dihydropyridines and pharmaceutical compositions containing them
HUT42330A (en) Process for producing pharmaceutical compositions containing histic plasminogene activators
HUT44180A (en) Process for producing new topical systhemic pharmaceutical compositions
HUT49481A (en) Improved process for producing pharmaceutical compositions containing calcium-salts
HU900191D0 (en) Process for preparation of 1,1,1-trifluor-2-aryl-propane-3-ols
HUT48624A (en) Process for producing 6-benzoxazinyl- and 6-benzothiazinyl-2,3,4,5-tetrahydropyridazin-3-ones and pharmaceutical compositions comprising such compounds
DE3662256D1 (en) Process for the preparation of (2,2)-paracyclophane
HUT46857A (en) Process for producing pharmaceutical compositions for treating bone-hurts
HUT54041A (en) Process for producing stable pharmaceutical compositions
HUT47428A (en) Process for producing retarde pharmaceutical compositions containing ketotifen
DE3569375D1 (en) Process for the preparation of 1,2-benzisothiazolones
HUT46303A (en) Process for producing 3-/omega-/3,5-di-/tetrabutil/-4-hydroxy-phenyl/-alkanoyl/-pyrroles andtheyr deoxy-analogues and pharmaceutical compositions containing them
HUT41753A (en) Process for producing 1,4-benzothiazine derivatives and pharmaceutical compositions containing them
HUT41984A (en) Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
HUT44524A (en) Process for producing 1,3-thiazolyl- or 1,3,4-thiadiazolyl- derivatives and pharmaceutical compositions containing them
HUT41762A (en) Process for producing thieno-benzo-pyranes, -thiopyranes and naphtothiophenes and pharmaceutical compositions containing them
HUT44942A (en) Process for producing pharmaceutical compositions for inhibiting thromogenesis
HUT43490A (en) Process for producing pharmaceutical compositions containing 2-alkoxy-(1-azabicyclo-(-2,2,2-)-okt-3-yl-benzamide)-n-oxide derivatives
HUT38537A (en) Process for producing pharmaceutical compositions containing peneme or carbapeneme antibiotics
PT83799A (en) Process for the preparation of novel 2,2:-bi-1h-imidazoles
HUT45261A (en) Process for producing 7-oxo-4-thia-1-aza-bicyclo/3.2.0/-hept-2-ene derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee